Correlation Between Fennec Pharmaceuticals and Rezolute

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fennec Pharmaceuticals and Rezolute, you can compare the effects of market volatilities on Fennec Pharmaceuticals and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and Rezolute.

Diversification Opportunities for Fennec Pharmaceuticals and Rezolute

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Fennec and Rezolute is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and Rezolute go up and down completely randomly.

Pair Corralation between Fennec Pharmaceuticals and Rezolute

Given the investment horizon of 90 days Fennec Pharmaceuticals is expected to generate 0.7 times more return on investment than Rezolute. However, Fennec Pharmaceuticals is 1.42 times less risky than Rezolute. It trades about 0.04 of its potential returns per unit of risk. Rezolute is currently generating about -0.2 per unit of risk. If you would invest  616.00  in Fennec Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  30.00  from holding Fennec Pharmaceuticals or generate 4.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fennec Pharmaceuticals  vs.  Rezolute

 Performance 
       Timeline  
Fennec Pharmaceuticals 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Fennec Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Fennec Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.
Rezolute 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Rezolute has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Fennec Pharmaceuticals and Rezolute Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fennec Pharmaceuticals and Rezolute

The main advantage of trading using opposite Fennec Pharmaceuticals and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.
The idea behind Fennec Pharmaceuticals and Rezolute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation